1. Critical role of the central 139-loop in stability and binding selectivity of arrestin-1. Vishnivetskiy SA, Baameur F, Findley KR, Gurevich VV (2013) J Biol Chem 288(17): 11741-50
    › Primary publication · 23476014 (PubMed) · PMC3636863 (PubMed Central)
  2. Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. Vishnivetskiy SA, Ostermaier MK, Singhal A, Panneels V, Homan KT, Glukhova A, Sligar SG, Tesmer JJ, Schertler GF, Standfuss J, Gurevich VV (2013) Cell Signal 25(11): 2155-62
    › Primary publication · 23872075 (PubMed) · PMC3774132 (PubMed Central)
  3. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding. Kook S, Zhan X, Kaoud TS, Dalby KN, Gurevich VV, Gurevich EV (2013) J Biol Chem 288(52): 37332-42
    › Primary publication · 24257757 (PubMed) · PMC3873585 (PubMed Central)
  4. The origin and evolution of G protein-coupled receptor kinases. Mushegian A, Gurevich VV, Gurevich EV (2012) PLoS One 7(3): e33806
    › Primary publication · 22442725 (PubMed) · PMC3307776 (PubMed Central)
  5. Synthetic biology with surgical precision: targeted reengineering of signaling proteins. Gurevich VV, Gurevich EV (2012) Cell Signal 24(10): 1899-908
    › Primary publication · 22664341 (PubMed) · PMC3404258 (PubMed Central)
  6. ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands. Aguila B, Coulbault L, Davis A, Marie N, Hasbi A, Le bras F, Tóth G, Borsodi A, Gurevich VV, Jauzac P, Allouche S (2012) Cell Signal 24(3): 699-707
    › Primary publication · 22101011 (PubMed) · PMC3392209 (PubMed Central)
  7. Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. Breitman M, Kook S, Gimenez LE, Lizama BN, Palazzo MC, Gurevich EV, Gurevich VV (2012) J Biol Chem 287(23): 19653-64
    › Primary publication · 22523077 (PubMed) · PMC3366000 (PubMed Central)
  8. Role of receptor-attached phosphates in binding of visual and non-visual arrestins to G protein-coupled receptors. Gimenez LE, Kook S, Vishnivetskiy SA, Ahmed MR, Gurevich EV, Gurevich VV (2012) J Biol Chem 287(12): 9028-40
    › Primary publication · 22275358 (PubMed) · PMC3308753 (PubMed Central)
  9. Manipulation of very few receptor discriminator residues greatly enhances receptor specificity of non-visual arrestins. Gimenez LE, Vishnivetskiy SA, Baameur F, Gurevich VV (2012) J Biol Chem 287(35): 29495-505
    › Primary publication · 22787152 (PubMed) · PMC3436164 (PubMed Central)
  10. Ligand directed signaling differences between rodent and human κ-opioid receptors. Schattauer SS, Miyatake M, Shankar H, Zietz C, Levin JR, Liu-Chen LY, Gurevich VV, Rieder MJ, Chavkin C (2012) J Biol Chem 287(50): 41595-607
    › Primary publication · 23086943 (PubMed) · PMC3516711 (PubMed Central)